INCY:NASDAQ
Incyte Corp
$124.65
arrow_downward
-0.53%(-0.66) 1D
$124.65
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 21, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$125.00
High
$127.41
Low
$124.19
Mkt. cap
25.27B
Avg. vol.
1.36M
Volume
1.27M
P/E ratio
15.88
52-wk high
$132.60
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$125.00
High
$127.41
Low
$124.19
Mkt. cap
25.27B
Avg. vol.
1.36M
Volume
1.27M
P/E ratio
15.88
52-wk high
$132.60
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
10 hours ago
FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week
GuruFocus
·
13 hours ago
INCY Looks 18.6% Overvalued on GF Value™ as of September 2026
AD HOC NEWS
·
15 hours ago
Incyte stock heads into the open after a 1.8% pullback
Investing.com
·
1 day ago
Specialised Therapeutics expands Incyte partnership to Australia
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com